Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Takeda presents new orally active antitumor agent for HER2-positive cancers

April 22, 2002

Small-molecule GnRH antagonist with good oral bioavailability presented at AACR meeting

April 22, 2002

Small-molecule inhibitors of FAH designed at Bayer as potential agents for NSCLC

April 22, 2002

CKD-732 examined for pharmacokinetic and metabolic profile in vitro and in vivo

April 22, 2002

All four components of PHY-906 necessary for biological activity as chemotherapy adjuvant

April 22, 2002

Lead Androgenics compound blocks androgen receptor activation at an early step

April 22, 2002

Novogen's phenoxodiol stabilizes tumor growth with minimal toxicity

April 19, 2002

Irofulven trial in refractory pancreatic cancer discontinued

April 19, 2002

Isoliquiritigenin shows potential as a prostate cancer preventive

April 19, 2002

Palonosetron effective for the treatment of chemotherapy-induced nausea and vomiting

April 19, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D
BioWorld Science
Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.